You are currently accessing the institutional-grade blueprint for <b>Cardiac Medications: Management of Complex Cardiovascular Disorders – Karen M. Marzlin</b>. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.
Full Day
Join Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC, CHFN, for an insightful and practical day focused on the common types of cardiac disorders that professionals like you see in your practice, and the medications currently used to treat them.
Purchase Cardiac Medications: Management of Complex Cardiovascular Disorders – Karen M. Marzlin courses at here with PRICE $199.99 $85
Join Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC, CHFN, for an insightful and practical day focused on the common types of cardiac disorders that professionals like you see in your practice, and the medications currently used to treat them.
Drawing from three decades of experience treating cardiology patients, Karen will provide you with cutting-edge information regarding the selection of particular cardiac medications, the desired outcomes, potential side effects and drug interactions. Leave with a clear understanding of the physiological basis for cardiovascular drug therapy and drugs used to manipulate hemodynamic parameters, alter the cardiac electrical system, interrupt the clotting process, and to treat a variety of cardiovascular disease states.
Don’t miss this opportunity to keep pace with the ever-changing field of cardiac care, and through the information gained in this seminar, reduce the risk of potential adverse consequences for your patients. You will leave with a holistic perspective of cardiovascular pharmacology and its role in providing your patient with better outcomes and quality of life.
- Justify the physiological basis for cardiovascular drugs used to support hemodynamics and optimize cardiac output.
- Select options in the treatment of dyslipidemia and hypertension by contrasting the differences in lipid lowering agents and comparing the similarities in antihypertensive agents.
- Communicate key evidence that guides decision-making regarding pharmacological choices in patients with atrial fibrillation.
- Assess the pharmacology in the patient with acute coronary syndrome with short-term and long-term treatment goals.
- Determine the role of pharmacological agents in interrupting abnormal neurohormonal responses in patients with heart failure.
- Evaluate patient partnering as a method of optimizing medication effectiveness.
Hemodynamics and Shock
- Physiological determinants of myocardial performance
- Vasodilators
- Vasopressors
- Inotropes
- Shock: Dopamine versus Norepinephrine
- Nuances of decompensated heart failure
Risk Factor Optimization
- Statin therapy in primary and secondary prevention
- Other Antilipid agents: when to use what?
- Outcome trials for lipid lowering agents
- AIM High
- Thrive
- Drug choices in hypertension
- Resistant hypertension
Atrial Fibrillation
- Antiarrhythmic pharmacology for rate control
- Antiarrhythmic pharmacology for rhythm control
- Clinical implications of potassium channel blockers
- Special considerations for Dronedarone and Amiodarone
- Anticoagulant medication options
- Fibrinolytics
- Anticoagulants
- Antiplatelets
Therapeutic Advances for Acute Coronary Syndrome
- Prasugrel
- Ticagrelor
- Epleranone post-STEMI
- Non-Steroidals
- ASA and CABG
- Contrast nephropathy
Heart Failure
- Optimal loop diuretic / dose and route of administration
- Nesiritide
- OPTIME Trial
- Serelaxin
- RAAS drugs
- Evidence-based beta blockers
- Drugs not to give for systolic dysfunction
Pulling it All Together: A Patient-Centered Approach to Pharmacology and Prescribing
Tag: Cardiac Medications: Management of Complex Cardiovascular Disorders – Karen M. Marzlin Review. Cardiac Medications: Management of Complex Cardiovascular Disorders – Karen M. Marzlin download. Cardiac Medications: Management of Complex Cardiovascular Disorders – Karen M. Marzlin discount.
Purchase Cardiac Medications: Management of Complex Cardiovascular Disorders – Karen M. Marzlin courses at here with PRICE $199.99 $85
Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results.<br><br><b>Asset Classification:</b>

Mastering Lab Interpretation: Deciphering the Hidden Clues - Sean G. Smith
Encyclopedia Of Language And Linguistics - Keith Brown
Steve Gordon - The Unstoppable Referrals Launchpad
How To Build A Craigslist Real Estate Lead Generating System
Branding & Duplication Playbook
Tai Chi Chin Na - Yang Jwing Ming
Kicking Off 2022 With A Bang - Geekout Dubai
$8K Per Day Formula - Chris Record
"Diamond Wealth of Being" Activation - Jacqueline Joy
Erle Montaigue - How to And How Not To Kick in the Internal Arts
[Download Now] REWW Academy – Real Estate Wholesaling Mastery
Seller Financing 2021 - Ron LeGrand
Rachel Rodger - Small Business Bodyguard
THE VAULT: The Ultimate Bundle of Resources for Seducers - PUA DATING TIPS